We recognise that the global healthcare market is rapidly evolving, with increasing pressure to define the value of new interventions. Global and national policies are directly influencing the price of, and access to, new treatments. Navigating this arena is complex and demanding. As the rate of medical innovation accelerates, competing demands from stakeholders continues to put pressure on those involved in the development and delivery of effective interventions, with particular challenges in generating evidence of value. We take a holistic, creative approach to defining the value of products by working in collaboration with clients; we provide strategic and tactical market access support and direction across the development cycle. We understand the external environment, and our market access roadmap ensures that we build a strategic partnership from the very beginning of our engagement with clients. We know what it takes to successfully introduce novel interventions and we partner with our clients on that journey to market. To optimise market access, there are numerous activities that need to be performed along the development pathway. Our expansive global market access capabilities ensure we meet clients’ specific needs by working together.
Our teams include thought leaders in the healthcare industry, with a passion for the advancement of healthcare and commitment to changing the healthcare landscape. We share the ownership to ensure that our clients’ healthcare interventions contribute favourable and demonstrable outcomes of value. Our centres of excellence are the cornerstone of our strategic partnership and include global market access solutions, resources, and education; global payer strategy, health economics and outcomes research, real world evidence; health technology assessment and value communications. Our centres of excellence have a successful track record of working alongside client functional teams in long-standing strategic partnerships.